<DOC>
	<DOCNO>NCT00968396</DOCNO>
	<brief_summary>The goal clinical research study learn clean stem cell patient multiple myeloma ( MM ) bone marrow relative make cell product capable replace bone marrow standard treatment chemotherapy .</brief_summary>
	<brief_title>Ex-Vivo Depletion Myeloma Cells From Peripheral Blood Progenitor Cell Grafts</brief_title>
	<detailed_description>A transplant one 's bone marrow stem cell part standard treatment MM . Because MM come bone marrow , stem-cell product bone marrow tumor cell mixed transplant . This may cause disease return transplant . This study learn method cleaning , `` purging , '' MM tumor cell stem cell use bone marrow relative . Study Drugs : Melphalan design damage DNA ( genetic material ) cell , may cause cancer cell die . Study Drug Administration : If find eligible take part study , give G-CSF twice day needle skin Days 1-5 move stem cell bone marrow blood . You receive melphalan needle vein 30 minute time 2 day directly receive stem cell transplant . Stem Cell Collection , Purging , Transplantation : On Day 5 , stem cell collection begin . You central venous catheter ( CVC - sterile , flexible tube ) place vein chest local anesthesia . Your doctor explain procedure detail , require sign separate consent form procedure . Blood remove body CVC pass machine separate stem cell cell . The stem cell frozen storage , blood return body . This 3-hour process call apheresis . This process do 1 time day 1-6 day , enough stem cell collect . Your stem cell place sterile container , grow multiply donated stem cell relative . If enough cell 2 week , cell transplant back body . If enough cell 2 week grow donor 's stem cell , combine sample set aside initial collection transplant back body . Study Visits : One ( 1 ) , 2 , 6 month transplant , blood ( 2 teaspoon ) draw routine test check status disease . Six ( 6 ) month transplant , also bone marrow aspirate/biopsy check status disease . Length Study : You remain study 12 month transplant . You take study disease get bad need treatment . End-of-Treatment Visit : Twelve ( 12 ) month transplant , end-of-treatment visit . At time , follow test procedure perform : - Blood ( 2 teaspoon ) draw routine test check status disease . - You bone marrow aspirate/biopsy . - You x-ray take bone . This investigational study . Melphalan FDA approve commercially available treatment MM . While receive stem-cell transplant standard treatment MM , cleaning ( purge ) stem-cell product investigational . Up 25 recipient take part study . All enrol M. D. Anderson</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>1 . Patients multiple myeloma relapse autologous transplant chemosensitive relapse one year post initial therapy 2 . Age 18 75 year 3 . Left ventricular ejection fraction &gt; /= 40 % . No uncontrolled arrhythmias 4 . FEV1 , FVC DLCO &gt; /= 40 % . No symptomatic pulmonary disease 5 . Serum bilirubin &lt; /= 2 x upper limit normal , SGPT &lt; /= 4 x upper limit normal 6 . HIVnegative 7 . Negative Beta HCG test woman child bear potential , define postmenopausal 12 month previous surgical sterilization 8 . Patient guardian able sign inform consent 9 . MarrowMSC Donor Requirements : patient must family member match 2 , 3 , 4 HLA antigen willing donate 80100 ml bone marrow MSC generation 1. International Staging System ( ISS ) stage I diagnosis ( beta2 microglobulin &lt; 3.5 mg/L albumin &gt; /= 3.5 g/dL ) 2 . Patients apheresis collection &lt; /= 7 x 10e6 CD34+/Kg 3 . A fully match relate donor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Myeloma</keyword>
	<keyword>Ex-Vivo Depletion Myeloma Cells</keyword>
	<keyword>Peripheral Blood Progenitor Cell Grafts</keyword>
	<keyword>PBPC</keyword>
	<keyword>Stem Cell Transplant</keyword>
	<keyword>Bone marrow stem cell</keyword>
	<keyword>Melphalan</keyword>
	<keyword>Alkeran</keyword>
	<keyword>Apheresis</keyword>
</DOC>